MONMOUTH JUNCTION, N.J. (AP) _ CytoSorbents Corp. (CTSO) on Tuesday reported a loss of $10.9 million in its second quarter.

The Monmouth Junction, New Jersey-based company said it had a loss of 25 cents per share.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 14 cents per share.

The blood purification therapy company posted revenue of $8.5 million in the period, also falling short of Street forecasts. Four analysts surveyed by Zacks expected $9.6 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CTSO at https://www.zacks.com/ap/CTSO